FIELD: medicine, pharmaceuticals.
SUBSTANCE: disclosed are agent of formula I 
binding to Helicobacter pilori ex vivo and substance based thereon, as well as pharmaceutical composition, food supplement and method for identification of bacterial adhesine. Claimed substance comprises agent of formula 1 and carrier. In particular substance includes Galβ3GlcNAc. Said agent may by conjugated with oligosaccharide or ceramide. Claimed agent represents specifically binding epitope of lactotetraose or lactotetraosyl ceramide (Galβ3GlcNAcβ3Galβ-4Glc1Cer) having lactotetraosyl ceramide sfingolipide-like activity, and is useful in typing of Helicobacter pilori, in Helicobacter pilori binding inhibition and in identification of bacterial adhesine.
EFFECT: new substances for binding to Helicobacter pilori.
18 cl, 13 dwg, 3 tbl
| Title |
Year |
Author |
Number |
| NEW RECEPTORS FOR Helicobacter pylori AND USES THEREOF |
2002 |
- Miller-Podraza Khalina
- Teneberg Susann
- Ongstrem Jonas
- Karl'Sson Karl-Anders
- Natunen Jari
|
RU2306140C2 |
| EXTERNAL COW LIPOPOLYSACCHARIDE EPITOPE H. pylori |
2010 |
- Altman, Ehleonora
- Kharrison, Blehr A.
- Chandan, Vandana
|
RU2558257C2 |
| COVALENT CONJUGANTS BETWEEN ENDOPEROXIDES RELATED TO ARTEMIZININ AND FERRIFEROUS PROTEINS AND METHODS OF APPLICATION |
2003 |
- Laj Genri K.
- Sasaki Tomikazu
- Singkh Narendra P.
|
RU2325156C2 |
| NATURAL ANTITUMOR OR ANTIVIRAL SUBSTANCES AND THEIR APPLICATION |
1998 |
- Mori Tsuneatsu
- Guo Maovu
- Mori Etsuko
|
RU2205010C2 |
| CONSTRUCTION OF MODIFIED FILAMENTOUS BACTERIOPHAGE FOR TREATMENT OR PROPHYLAXIS OF BACTERIAL INFECTION, MODIFIED BACTERIOPHAGE M14, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OF BACTERIAL INFECTION, MONOCLONAL ANTIBODY, HYBRIDOMA (VARIANT) |
1997 |
|
RU2215032C2 |
| PEA PROTEIN PEPTIDES WITH ANTI-Helicobacter pylori ACTIVITY |
2011 |
- Georgi, Gil'Da Ehlize
- Ojler, Marko
- Mank, Marko
- Khenzel', Andreas
- Nikhjus, Mikhaehl'
- Klapperikh, Monika
- Shtal', Bernd
|
RU2558304C2 |
| PEPTIDE PHARMACEUTICAL COMPOSITION, BASED DRUG FOR GASTRODUODENAL DISEASES CAUSED BY HELICOBACTER PYLORI, AND METHOD OF USING IT |
2011 |
- Khavinson Vladimir Khatskelevich
- Kvetnoj Igor' Moiseevich
- Poljakova Viktorija Olegovna
- Ryzhak Galina Anatol'Evna
- Kozlov Lenar Vasil'Evich
|
RU2449805C1 |
| METHOD OF INDUCTION OF PROTECTIVE IMMUNE RESPONSE IN MAMMALS TO HELICOBACTER INFECTION, VACCINE FOR INDUCTION OF PROTECTIVE IMMUNE RESPONSE IN MAMMALS FOR HELICOBACTER INFECTION, METHOD OF INDUCTION OF PASSIVE PROTECTION IN MAMMALS AGAINST INFECTION WITH HELICOBACTER, AND METHOD OF ESTIMATION OF ENDOGENOUS IMMUNE RESPONSE IN MAMMALS INFECTED WITH HELICOBACTER |
1993 |
- P'Er Mishetti
- Andre Bljum
- Katrin Daven
- Rajner Khaas
- Iren Kortezi-Telaz
- Zhan-P'Er Krekhenbjul'
- Ehmilija Saraga
|
RU2125891C1 |
| BISMUTH SALTS OF ANTIBIOTICS OF GROUP MOENOMYCIN, METHOD OF THEIR PREPARING, THEIR USING AND MEDICINAL AGENTS CONTAINING SUCH SALTS |
1998 |
- Verteshi Laslo
- Kurts Mikhel'
- Markus Astrid
- Zajbert Gerkhard
|
RU2204565C2 |
| METHODS FOR DIAGNOSTICS |
2002 |
- Klejmola Vesa
- Ehrola Ehrkki
- Viander Markku
|
RU2309408C2 |
